Raydiant Oximetry is a Rosenman Innovator.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Read the full story at the Fogarty Institute website.
When Neil Ray, MD, founder and CEO of Fogarty Institute graduate Raydiant Oximetry and a board-certified anesthesiologist, learned about the global shortage of ventilators early in the COVID-19 crisis, he immediately considered ways that he, his colleagues and others in the Silicon Valley medtech ecosystem could help.
He first reached out to Russ DeLonzor, Raydiant Oximetry’s COO, who had previous experience working with ventilators as vice president of R&D at Nellcor Puritan-Bennett, which is now part of Medtronic’s portfolio, one of the largest medical device manufacturers of ventilators.
“Given my extensive experience using ventilators as an anesthesiologist, our experience in the industry and our network here in Silicon Valley, we were intrigued and encouraged by the idea of developing a safe, effective, low-maintenance and inexpensive ventilator that could save the lives of COVID patients with acute respiratory distress syndrome (ARDS),” said Neil.
“We were reading headlines regarding physicians in Italy having to make decisions on who would get a ventilator and who would potentially be left to die, and articles on U.S. states facing critical shortages of life-saving equipment. We knew there had to be a better way and had to do something to address this immense need,” added Russ.